Rejection, Transplant
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection (NCT00117689) | Genzyme, a Sanofi Company | 2005-04-01 |
Track Rejection, Transplant automatically
Every clearance here is in the API, with alerts when new ones post.